NEW VISITOR POLICY in effect as of Monday, March 30
See all Novel Coronavirus Information for Penn Medicine Patients
Recognized by America's Top Doctors, 2014 - 2018
Recognized by Best Doctors in America - 2013 - 2018
Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2019
Abramson Cancer Center
Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Nasioudis D, Sakamuri S, Ko EM, Haggerty AF, Giuntoli R, Burger RA, Morgan MA, Latif NA: Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma Gynecol Oncol Epub ahead of print : 2020.
Nasioudis D, Heyward QD, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Ko EM, Latif NA.: Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer. Surg Oncol Epub ahead of print : 2020.
Graul A, Haggerty A, Stickley C, Kumar P Morales K, Bogner H, Burger R, Morgan M, Ko E: Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care services among gynecologic oncology patients; A Randomized Controlled Trial Gynecol Oncol 156 (2): 482-7,2020.
Nasioudis D, Albright BB, Ko EM, Haggerty AF, Giuntoli II RL, Burger RA, Morgan MA, Latif NA: Advanced stage primary mucinous ovarian carcinoma. Where do we stand? Archives of Gynecology and Obstetrics In Press : 2020.
Zamarin D, Burger RA, Sill MW, Powell DJ, Lankes HA, Zivanovic O, Gunderson C, Ko E, Mathews C, Sharma S, Hagemann AR, Khleif S, Aghajanian C: A Randomized Phase II Trial of Nivolumab vs. Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study J Clin Oncol In Press : 2020.
Coleman RL, Handley KF, Burger RA, Dal Molin G, Stagg R, Sood A, Moore K.: Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial Gynecol Oncol In Press : 2020.
Nasioudis D, Ko EM, Haggerty AF, Cory L, Giuntoli II, RL, Burger RA, Morgan MA, Latif NA: Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy. Gynecol Oncol In Press : 2020.
Fu S, Burger RA, Hamilton E, Corr BR, Naumann RW, Wenham RM, Morgan MA, Stagg R, Moore KN: A phase Ib study of navicixizumab and weekly paclitaxel in heavily pretreated platinum resistant ovarian, primary peritoneal or fallopian tube cancer. Society of Gynecologic Oncology Annual Meeting on Women's Cancer : 2020.
Katsakhyan L, Baraban EG, Dumoff KL, Burger RA, Parikh R, Cooper K: The “Far Left” of the Morphologic Spectrum of Ovarian High-Grade Serous Carcinoma: Case report of a Purely Non-invasive High-Grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor International Journal of Gynecological Pathology In Press : 2020.
Yoon J-Y, Devin K, Ko EM, Latif NA, Burger RA, Reyes CM, Schwartz LE: Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary. USCAP 109th Annual Meeting, Los Angeles, CA : 2020.
University of Pennsylvania3400 Civic Center Blvd.South Tower 10-173
Phone: (215) 220-9513
Patient appointments: 800-789-7366